Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Michael Henry FioreEVP, Chief Commercial Officer | HealthequityHQY | Open-market sale10b5-1 plan | 05/29 | 06/02 | 3,142 sh | $95.00 | $298,490 | −5.0% |
Delano LaddEVP, General Counsel | HealthequityHQY | Open-market sale10b5-1 plan | 05/28 | 06/01 | 7,500 sh | $90.00 | $675,000 | −7.6% |
Gayle Furgurson WellbornDirector | HealthequityHQY | Open-market sale10b5-1 plan | 05/28 | 06/01 | 2,439 sh | $90.00 | $219,510 | −11.0% |
Delano LaddEVP, General Counsel | HealthequityHQY | Open-market sale10b5-1 plan | 25/12/19 | 25/12/23 | 1,500 sh | $94.72 | $142,080 | −2.0% |
Elimelech RosnerEVP, CTO | HealthequityHQY | Open-market sale | 25/12/18 | 25/12/19 | 10,959 sh | $95.45 | $1,046,036.55 | −19.3% |
Gayle Furgurson WellbornDirector | HealthequityHQY | Open-market sale | 25/12/12 | 25/12/16 | 4,339 sh | $98.03 | $425,352.17 | −18.0% |
Delano LaddEVP, General Counsel | HealthequityHQY | Open-market sale10b5-1 plan | 25/11/20 | 25/11/24 | 1,500 sh | $104.56 | $156,840 | −1.9% |
Delano LaddEVP, General Counsel | HealthequityHQY | Open-market sale10b5-1 plan | 25/10/20 | 25/10/22 | 1,500 sh | $92.07 | $138,105 | −1.9% |
Michael Henry FioreEVP, Chief Commercial Officer | HealthequityHQY | Open-market sale | 25/10/07 | 25/10/08 | 1,781 sh | $88.21 | $157,102.01 | −3.5% |
HealthequityHQY | Open-market sale10b5-1 plan | 25/09/19 | 25/09/22 | 6,000 sh3 trades | $94.10avg. | $564,628.56 | −7.0% | |
Evelyn S. DilsaverDirector | HealthequityHQY | Open-market sale | 25/09/05 | 25/09/09 | 3,461 sh | $93.30 | $322,911.3 | −6.7% |
HealthequityHQY | Open-market sale | 25/07/07 | 25/07/08 | 1,794 sh2 trades | $101.73avg. | $182,504 | −3.3% | |
HealthequityHQY | Open-market sale | 25/06/06–25/06/09 | 25/06/10 | 71,000 sh2 trades | $112.34avg. | $7,976,290 | −53.1% | |
HealthequityHQY | Open-market sale | 25/06/06 | 25/06/10 | 231,950 sh9 trades | $112.06avg. | $25,992,825.72 | No record | |
HealthequityHQY | Open-market sale10b5-1 plan | 25/04/09 | 25/04/11 | 5,750 sh3 trades | $77.66avg. | $446,519.91 | −6.3% | |
Michael Henry FioreEVP, Chief Commercial Officer | HealthequityHQY | Open-market sale10b5-1 plan | 25/04/04 | 25/04/08 | 8,881 sh | $78.26 | $695,027.06 | −13.6% |
HealthequityHQY | Open-market sale10b5-1 plan | 25/02/10 | 25/02/12 | 5,750 sh2 trades | $111.29avg. | $639,913.22 | −6.8% | |
Debra Charlotte McCowanDirector | HealthequityHQY | Open-market sale | 24/12/12 | 24/12/13 | 5,000 sh | $95.56 | $477,800 | −39.1% |
HealthequityHQY | Open-market sale | 24/12/12 | 24/12/13 | 25,000 sh2 trades | $96.72avg. | $2,417,936.8 | −56.7% | |
Elimelech RosnerEVP, CTO | HealthequityHQY | Open-market sale | 24/12/12 | 24/12/13 | 2,869 sh | $97.12 | $278,637.28 | −4.8% |